৳ 4/unit
Pack: ৳ 40
৳ 4/unit
Pack: ৳ 40
At a glance
Carbonic anhydrase inhibitor used in open-angle glaucoma, secondary glaucoma, edema, and as an adjuvant in epilepsy.
Indications
Indicated in open angle glaucoma, secondary glaucoma, and as an adjuvant in the treatment of edema and epilepsy.
Pharmacology
Acetazolamide inhibits carbonic anhydrase enzyme, decreasing the secretion of aqueous humor in the eye and dropping intraocular pressure. In the CNS, it retards abnormal paroxysmal neuronal discharges.
Dosage
Adults: Initially 250 mg (1 tablet) 4 times daily. Acute intraocular pressure: 2 tablets (500 mg) initially followed by 1 tablet every 6 hours. Children: 0.5 to 2 tablets in divided doses.
Side effects
Common: Headache, drowsiness, dizziness, fatigue, anorexia, polyuria, insomnia, gastrointestinal upset, and paresthesia.
Use in pregnancy
Pregnancy Category C. Use only if clearly needed and benefits outweigh potential risks to fetus.
Pregnancy Category: C — always consult a doctor before taking during pregnancy.
Precautions & warnings
Monitor serum electrolytes for hypokalemia or hyponatremia and observe for metabolic acidosis during long-term therapy.
Overdose effects
Overdose may cause electrolyte imbalance, metabolic acidosis, and CNS effects. Treatment is supportive.
Storage conditions
Store below 30°C. Protect from light and moisture. Keep out of reach of children.